Connect Biopharma Holdings Ltd
NASDAQ:CNTB
Income Statement
Earnings Waterfall
Connect Biopharma Holdings Ltd
Revenue
|
0
CNY
|
Operating Expenses
|
-64.9m
CNY
|
Operating Income
|
-64.9m
CNY
|
Other Expenses
|
5.4m
CNY
|
Net Income
|
-59.5m
CNY
|
Income Statement
Connect Biopharma Holdings Ltd
Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||
Operating Expenses |
(65)
|
(112)
|
(191)
|
(628)
|
(784)
|
(65)
|
|
Selling, General & Administrative |
(7)
|
(10)
|
(48)
|
(122)
|
(139)
|
(15)
|
|
Research & Development |
(59)
|
(106)
|
(151)
|
(518)
|
(652)
|
(52)
|
|
Other Operating Expenses |
1
|
4
|
8
|
12
|
8
|
1
|
|
Operating Income |
(65)
N/A
|
(112)
-72%
|
(191)
-70%
|
(628)
-229%
|
(784)
-25%
|
(65)
+92%
|
|
Pre-Tax Income | |||||||
Interest Income Expense |
(5)
|
3
|
(9)
|
(3)
|
22
|
6
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
(33)
|
0
|
|
Total Other Income |
(23)
|
(59)
|
(579)
|
(674)
|
0
|
0
|
|
Pre-Tax Income |
(94)
N/A
|
(169)
-80%
|
(779)
-362%
|
(1 305)
-67%
|
(795)
+39%
|
(59)
+93%
|
|
Net Income | |||||||
Tax Provision |
0
|
0
|
0
|
(2)
|
(2)
|
(0)
|
|
Income from Continuing Operations |
(94)
|
(169)
|
(779)
|
(1 307)
|
(797)
|
(60)
|
|
Income to Minority Interest |
17
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(77)
N/A
|
(169)
-119%
|
(779)
-362%
|
(1 307)
-68%
|
(797)
+39%
|
(60)
+93%
|
|
EPS (Diluted) |
-1.38
N/A
|
-3.02
-119%
|
-13.96
-362%
|
-22.73
-63%
|
-13.87
+39%
|
-1.08
+92%
|